NLRP7 and urinary bladder cancer: We found that 53.71% of all bladder cancer samples showed genetic mutations in the TCGA bladder cancer cohort and SCAF11 was the most frequent mutation frequency gene, followed by CASP8 and NLRP7 (Figure 1B).